Using Vibrio natriegens for high-yield production of challenging expression targets and for protein deuteration

por Mojica, Natalia, Kersten, Flore, Montserrat-Canals, Mateu, Huhn, G. Robb, Tislevoll, Abelone M., Cordara, Gabriele, Teter, Ken, Krengel, Ute
Publicado 2023

SUPPORT: 48-week results of fosamprenavir/ritonavir vs efavirenz with abacavir/lamivudine in under-represented, antiretroviral-naïve patients

por Kumar, P, DeJesus, E, Huhn, G, Sloan, L, Garcia, F, Small, C, Edelstein, H, Felizarta, F, Hao, R, Ha, B, Stancil, B, Ross, L, Oie, K, Pappa, K
Publicado 2010